Employees: NN (None)Legal category: 5470Size: PMECreation date: 2017-10-05 (8 years)Status: ActiveBusiness sector: Fonds de placement et entités financières similairesLocation: L'ILE-BOUCHARD (37220), Indre-et-Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE : revenue, balance sheet and financial ratios
AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE is a French company
founded 8 years ago,
specialized in the sector Fonds de placement et entités financières similaires.
Based in L'ILE-BOUCHARD (37220),
this company of category PME
shows in 2018 a net income positive of 119 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE (SIREN 837869668)
Indicator
2018
Revenue
N/C
Net income
118 562 €
EBITDA
-4 991 €
Net margin
N/C
Revenue and income statement
In 2018, AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE generates positive net income of 119 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
EBITDA (2018)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
-4 991 €
EBIT (2018)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-4 991 €
Net income (2018)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
118 562 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1039%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 91%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 10.8 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high.
Debt ratio (2018)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1038.873%
Financial autonomy (2018)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
91.219%
Repayment capacity (2018)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
10.808
Solvency indicators evolution AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
Debt ratio
1038.873
Financial autonomy
91.219
Repayment capacity
10.808
Cash flow / Revenue
None%
Sector positioning
Debt ratio
1038.872018
2018
Q1: 0.0
Med: 9.68
Q3: 69.31
Average
In 2018, the debt ratio of AGNES GOURON SPFPL DE PHA... (1038.87) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
91.22%2018
2018
Q1: 16.73%
Med: 60.92%
Q3: 90.64%
Excellent
In 2018, the financial autonomy of AGNES GOURON SPFPL DE PHA... (91.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
10.81 years2018
2018
Q1: 0.0 years
Med: 0.01 years
Q3: 3.23 years
Average
In 2018, the repayment capacity of AGNES GOURON SPFPL DE PHA... (10.81) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 5982.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2018)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
5982.534
Interest coverage (2018)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
-129.072
Liquidity indicators evolution AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
Liquidity ratio
5982.534
Interest coverage
-129.072
Sector positioning
Liquidity ratio
5982.532018
2018
Q1: 96.2
Med: 435.9
Q3: 2617.52
Excellent
In 2018, the liquidity ratio of AGNES GOURON SPFPL DE PHA... (5982.53) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
-129.07x2018
2018
Q1: -71.83x
Med: 0.0x
Q3: 0.0x
Average
In 2018, the interest coverage of AGNES GOURON SPFPL DE PHA... (-129.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Positioning of AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE in its sector
Comparison with sector Fonds de placement et entités financières similaires
Valuation estimate
Based on 170 transactions of similar company sales
(all years),
the value of AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE is estimated at
1 229 108 €
(range 761 868€ - 1 911 651€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2018
170 transactions
761k€1229k€1911k€
1 229 108 €Range: 761 868€ - 1 911 651€
NAF 5 all-time
Valuation method used
Net Income Multiple
118 562 €
×
10.4x
=1 229 109 €
Range: 761 869€ - 1 911 651€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 170 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Fonds de placement et entités financières similaires)
Compare AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE with other companies in the same sector:
Frequently asked questions about AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE
What is the revenue of AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE ?
The revenue of AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE is not publicly disclosed (confidential accounts filed with INPI).
Is AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE profitable?
Yes, AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE generated a net profit of 119 k€ in 2018.
Where is the headquarters of AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE ?
The headquarters of AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE is located in L'ILE-BOUCHARD (37220), in the department Indre-et-Loire.
Where to find the tax return of AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE ?
The tax return of AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE operate?
AGNES GOURON SPFPL DE PHARMACIEN D'OFFICINE operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart